Imphal News Flash

Antinuclear Antibody Test Market Size Is Likely To Be Valued At USD 2.36 Billion By 2025 | Grand View Research, Inc.

 Breaking News
  • No posts were found

Antinuclear Antibody Test Market Size Is Likely To Be Valued At USD 2.36 Billion By 2025 | Grand View Research, Inc.

April 02
00:51 2021
Antinuclear Antibody Test Market Size Is Likely To Be Valued At USD 2.36 Billion By 2025 | Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
According to Grand View Research, Inc., the Antinuclear Antibody Test Market remained unscathed during the ongoing Covid-19 pandemic and is showcasing a promising growth trend by 2025. The test is now widely employed for the careful evaluation of incidental skin changes as a dermatological manifestation of Covid-19 infection.

The global antinuclear antibody test market size is expected to reach USD 2.36 billion by 2025 and is projected to expand at a CAGR of 12.5% over the forecast period. Rising adoption of the ANA test and an increase in government initiatives to treat autoimmune disorders are the primary factors driving the market. Furthermore, the rising incidence of autoimmune disorders is set to fuel the growth from 2018 to 2025.

From the point of view of rheumatology bioinformatic analyses, antinuclear antibody tests have gained a prominent demand to evaluate the role of SARS-CoV-2 in inflammatory and viral arthritis and are essential for diagnosis. The market experienced staggering growth in 2020 and continues to observe an upsurge in demand as studies reveal the correlation between the occurrence of viral arthritis and skin inflammation, thus making it vital to recognize the pathogenesis of COVID-19 and its clinical phenotypes. 

Antinuclear Antibody Test Market Highlights

Based on products, reagents and assay kits was the leading segment in 2017 and is anticipated to register the fastest growth by 2025 owing to the high product adoption of in clinical and research settings

Based on technique, immunofluorescence assay accounted for the highest revenue share in 2017 owing to its high adoption compared to other available techniques

Based on application, rheumatoid arthritis segment is projected to grow at the fastest rate due to the increasing incidence of the disease

North America was the leading regional segment in 2017, on account of the high adoption of ANA testing, presence of a robust healthcare infrastructure, and patient awareness

For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/antinuclear-antibody-ana-test-market/request/rs1

Antinuclear Antibody Test Market Segmentation

Grand View Research has segmented the global antinuclear antibody test market on the basis of product, technique, application, end use, and region:

Antinuclear Antibody Test Product Outlook (Revenue, USD Million, 2014 – 2025)

     Reagents & Assay Kits
     Systems
     Software & Services 

Antinuclear Antibody Test Technique Outlook (Revenue, USD Million, 2014 – 2025)

     ELISA
     Immunofluorescence Assay
     Multiplex Assay

Antinuclear Antibody Test Application Outlook (Revenue, USD Million, 2014 – 2025)

     Rheumatoid Arthritis
     Systemic Lupus Erythematosus
     Sjogren’s Syndrome
     Scleroderma
     Others

Antinuclear Antibody Test End-use Outlook (Revenue, USD Million, 2014 – 2025)

     Hospitals
     Clinical Laboratories
     Physician Office Laboratories
     Others

Antinuclear Antibody Test Regional Outlook (Revenue, USD Million, 2014 – 2025)

     North America
        • The U.S.
        • Canada
     Europe
        • Germany
        • U.K.
     Asia Pacific
        • China
        • India
        • Japan
    • Latin America
        • Brazil
        • Mexico
     Middle East & Africa
        • South Africa

List of Key Players in Antinuclear Antibody Test Market

  • Thermo Fisher Scientific Inc.
  • Alere Inc.
  • Bio-Rad Laboratories.
  • Antibodies Inc.
  • Immuno Concepts
  • Zeus Scientific
  • Inova Diagnostics
  • Erba Diagnostics
  • Euroimmun AG
  • Trinity Biotech PLC.

 

Speak to Analyst @ https://www.grandviewresearch.com/inquiry/5462/ibb

Browse More Related Report:

COVID-19 Diagnostics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Reagents & Kits, Services), By Sample Type, By Test Type, By Mode, By End Use, And Segment Forecasts, 2021 – 2027

Clinical Laboratory Service Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology), By Service Provider, By Application, By Region, And Segment Forecasts, 2021 – 2028

About Grand View Research

Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/antinuclear-antibody-ana-test-market


Warning: count(): Parameter must be an array or an object that implements Countable in /home/indoreonlinejour/imphalnewsflash.in/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share